Skip to main content

Convergence of scaffold-guided bone regeneration and RIA bone grafting for the treatment of a critical-sized bone defect of the femoral shaft



Critical-sized bone defects, mainly from trauma, infection or tumor resection are a challenging condition, often resulting in prolonged, complicated course of treatment. Autografts are considered as the gold standard to replace lost bone. However, limited amount of bone graft volume and donor-site morbidity have established the need for the development of alternative methods such as scaffold-based tissue engineering (TE). The emerging market of additive manufacturing (3D-printing) has markedly influenced the manufacturing of scaffolds out of a variety of biodegradable materials. Particularly medical-grade polycaprolactone and tricalcium phosphate (mPCL–TCP) scaffolds show appropriate biocompatibility and osteoconduction with good biomechanical strength in large preclinical animal models. This case report aims to show first evidence of the feasibility, safety, and efficacy of mPCL–TCP scaffolds applied in a patient with a long bone segmental defect.

Case presentation

The presented case comprises a 29-year-old patient who has suffered a left-sided II° open femoral shaft fracture. After initial external fixation and subsequent conversion to reamed antegrade femoral nailing, the patient presented with an infection in the area of the formerly open fracture. Multiple revision surgeries followed to eradicate microbial colonization and attempt to achieve bone healing. However, 18 months after the index event, still insufficient diaphyseal bone formation was observed with circumferential bony defect measuring 6 cm at the medial and 11 cm at the lateral aspect of the femur. Therefore, the patient received a patient-specific mPCL–TCP scaffold, fitting the exact anatomical defect and the inserted nail, combined with autologous bone graft (ABG) harvested with the Reamer–Irrigator–Aspirator system (RIA—Synthes®) as well as bone morphogenetic protein-2 (BMP-2). Radiographic follow-up 12 months after implantation of the TE scaffold shows advanced bony fusion and bone formation inside and outside the fully interconnected scaffold architecture.


This case report shows a promising translation of scaffold-based TE from bench to bedside. Preliminary evidence indicates that the use of medical-grade scaffolds is safe and has the potential to improve bone healing. Further, its synergistic effects when combined with ABG and BMP-2 show the potential of mPCL–TCP scaffolds to support new bone formation in segmental long bone defects.

Case report


Critical-sized bone defects (> 5 cm) can be the result of a traumatic event, a malignant disease or (infectious) non-union. Currently established treatment options for the reconstruction of such large bone defects are autologous (vascularized) bone transfer, segmental bone transport or the Masquelet technique.

Yet, all of the above listed techniques have several drawbacks. Autologous bone transfer not only possesses a substantial harvesting morbidity, but also the exact fitting of the graft into the defect zone is often demanding and bony ingrowth of the graft is frequently not achieved right away. Segmental transport is a very lengthy and demanding procedure and often associated with external stabilization and therefore with low patient comfort. Further, the final docking process of the transported bone often requires several docking procedures [1, 2]. Standalone Masquelet technique has shown promising results in some surgeons practice; however graft resorption appears to be a major problem with highly heterogeneous bone formation capacity often resulting in multiple additional interventions [3]. Further, it remains undetermined which osteoinductive and osteoconductive material should best be put inside the Masquelet membrane [4, 5].

In recent years, significant advances have been made in the convergence of 3D-printing and scaffold-guided bone regeneration [6,7,8]. For example, biodegradable, customized composite scaffolds can be 3D-printed by using medical-grade polycaprolactone (mPCL) in combination with β-tricalcium phosphate (β-TCP), which can be precisely fitted into the bony defect zone.

Case presentation

A 29-year-old patient suffered a left-sided II° open femoral shaft fracture and an unstable pelvic injury. Initially, the bony injuries were stabilized with external fixation and converted to a definitive stabilization with a reamed antegrade femoral nail for the femoral shaft fracture after one week (Fig. 1). Six weeks following the nail insertion, an infection in the area of the formerly open fracture with a multi-resistant Gram-negative Escherichia coli (3-MRGN) occurred, requiring nail removal, resection of avital bone, subfascial vacuum therapy and external fracture fixation. During subsequent revision surgeries through a lateral approach to the femur, sterile wound conditions were achieved, and the bony defect prepared for Masquelet technique by insertion of a vancomycin cement seal in order to induce a vascularized membrane (Fig. 2). Four weeks after induction of the Masquelet membrane, the vascularized membrane was cautiously opened through the lateral approach and the cement seal was removed. Now, the external fixation was removed, and the femoral defect was again bridged and stabilized with a reamed antegrade femoral nail, which was cautiously passed through the former position of the cement seal surrounded by the vascularized membrane. The membrane was then filled with Reamer–Irrigator–Aspirator® (RIA) bone grafting, harvested from the contralateral femur, mixed with Cerament G® (BONESUPPORT AB, Lund, Sweden) and finally closed by suture (Fig. 3). The microbiological samples obtained during this operation again confirmed sterile wound conditions in long-term incubation.

Fig. 1
figure 1

Left-sided II° open femoral shaft stabilized with a reamed antegrade femoral nail

Fig. 2
figure 2

Preparation of the defect for Masquelet technique by insertion of a vancomycin cement seal in order to induce a vascularized membrane

Fig. 3
figure 3

Reamed antegrade femoral nail and Masquelet membrane filled RIA bone grafting mixed with Cerament G®

Ten months following the antegrade nail insertion and the Masquelet grafting procedure, the patient presented with ongoing pain during loadbearing and radiologically showed a persistent non-union (Fig. 4). Within revision surgery, non-vital bone was resected and a tricortical iliac crest graft inserted press fit in the lateral aspect of the femur and additionally secured with a reconstruction plate (Fig. 5). Additionally, Cerament G® was applied to the lateral aspect of the non-union.

Fig. 4
figure 4

RIA bone graft resorption and persistent non-union 10 months following surgery

Fig. 5
figure 5

Revision surgery with tricortical iliac crest graft, Cerament G® and additionally plating with a reconstruction plate

Seven months after tricortical iliac crest grafting, the patient suffered persistent pain during loadbearing and radiologically the graft was almost completely resolved (Fig. 6). Due to the failure of achieving bone healing applying commonly used methods the patient was then prepared for insertion of a customized, biodegradable 3D mPCL–TCP scaffold (Table 1).

Fig. 6
figure 6

Completely resolved tricortical iliac graft 7 months after surgery

Table 1 Summary of surgical methods applied to achieve bone healing prior to utilization of an individual healing attempt with a tissue-engineered construct including a medical-grade polycaprolactone and tricalcium phosphate scaffold

Therefore, a computed tomography (CT)-scan was obtained and processed by Osteopore® to produce an individualized scaffold by additive manufacturing. The circumferential bony defect now measured 6 cm at the medial and 11 cm at the lateral aspect of the femur. During surgery, the reconstruction plate was removed, and the nail was circumferentially exposed over the former lateral access. RIA bone grafting was obtained from the ipsilateral tibia and filled into the customized mPCL–TCP scaffold (Fig. 7). Then, the three composite scaffolds were circumferentially pressed on the nail to fill the defect space (Fig. 8) and finally covered with a bone morphogenetic protein-2-impregnated collagen membrane.

Fig. 7
figure 7

Customized, biodegradable 3D mPCL–TCP scaffold (Osteopore®) filled with RIA bone grafting

Fig. 8
figure 8

The scaffold was circumferentially pressed on the nail and finally covered with a BMP-2-impregnated membrane

Twelve months after surgery, the patient presented with no pain under full weight bearing and the X-ray shows delicate but adequate bone formation. A CT-scan confirms almost complete bony fusion of the critical-sized defect and bone formation inside and outside the fully interconnected scaffold architecture (Fig. 9).

Fig. 9
figure 9figure 9

a X-ray 12 months after surgery shows delicate but adequate bone formation. b CT-scan 12 months after surgery confirms almost complete bony fusion of the critical-sized defect with partial degradation of the mPCL–TCP scaffold


A paramount requirement for healing of critical-sized defects is the establishment of an osteogenetically inductive and conductive environment paired with mechanical stability (diamond concept) [9]. Autologous grafts, like vascularized fibula transfer or iliac crest, offer a satisfying combination of above-mentioned biological and mechanical properties and are therefore still considered the gold standard [10]. However, its use is limited by several factors, including limited bone graft size and volume and donor-site morbidity with persistent pain at the iliac crest after bone graft harvesting in up 30% [11,12,13]. Further, critical-sized defects filled with a fibula or iliac crest graft are usually stabilized either with a plate or an external fixation because they are not accessible for a biomechanically superior nail osteosynthesis due to a missing canal. Nail osteosynthesis may be performed in combination with the Masquelet technique [14]: after induction of the Masquelet membrane the void is filled with RIA bone grafting. Despite several reported excellent results in the literature as well as in our hands [4, 15, 16], extensive graft resorption and weakness of the reconstructed segment, probably due to a missing osteoconduction, is a major drawback of this technique. The problem of RIA bone graft resorption despite insertion into a vascularized membrane can be seen in the above illustrated case. The failure of the tricortical iliac crest graft in our presented case may be due to two factors: first, this type of graft is difficult to insert press fit into a larger three-dimensional complex defect, especially in case of an already inserted nail, and secondly only partly addresses the volume of the circumferential defect.

In the past decades, scaffold-guided bone tissue engineering has emerged as a promising strategy to overcome the shortcomings associated with established techniques [17,18,19]. The ability of 3D-printing allows the design and manufacture of osteoconductive scaffolds which are optimized for clinical translation in terms of pore size, layering, and degradation [20]. Equipping the scaffolds with osteogenic as well as osteoinductive properties is a condition sine qua non; yet this is a highly demanding process with several challenges. For example, the seeding of the scaffold with mesenchymal precursor cells in order to gain osteogenetic properties is possible; however, several drawbacks have to be kept in mind. First, this requires a harvesting surgical procedure and an ex vivo cultivation of the cells, which has been shown to reduce the osteogenetic potential as well as affect phenotype and behavior of these cells [21, 22]. Secondly, sterilization of the seeded scaffolds is difficult and may further reduce the biological potential. Thirdly, new biodegradable material directly coupled with a biologic may face the most difficult FDA class 3 regulatory approval [23]. So overall, this is an extremely demanding and expensive process reducing the suitability for routine clinical use.

Our approach, illustrated in the above presented case, separates the diamond concept into three independent workflows, which are easily merged during surgery: 3D-printing of a well-designed biodegradable scaffold with osteoconductive properties, which is intraoperatively packed with osteogenetic and osteoinductive highly potent RIA bone grafting [24,25,26]. Mechanical stability is achieved with an intramedullary nail on which the customized RIA bone graft filled scaffold is circumferentially clipped.

There are various advantages of this clinically driven methodology. First of all, this approach allows usage of an intramedullary nail as the mechanically most robust implant for long bone stabilization with critical-sized defects. Secondly, customized printing according to a CT-scan allows for an individualized and optimal fit of the scaffold in the defect and around the nail. Further, the 3D-printing in layering technique allows creation of a high porosity (70%) with interconnected pores of 800–2000 µm, which is reported to be a design requirement for large-volume segmental tibia and femur defect in a preclinical model [27, 28]. The usage of medical-grade PCL and ß-TCP in an 80:20 ratio further offers the suitable mechanical properties and degradation kinetics by hydrolysis as compared to unpredictable resorption of fast degrading natural and synthetic polymers. Briefly, PCL is a biopolymer with excellent biocompatibility and biodegradability [29] causing no local inflammation [30] and no accumulation in organs [31]. The pore geometry of a scaffold with collagen fiber network eventually functions as a cell-deposit template. Thereby, it fosters vascular ingrowth which builds a proper microenvironment facilitating oxygen and nutrient transport to the inner part of the scaffold essential for bone repair and crucial for avoiding premature bone graft resorption [18, 32]. By inclusion of TCP and manufacturing of the mPCL–TCP composites osteoconductivity of scaffolds further increases resulting in the production of a scaffold providing structural support for cell attachment and tissue development suitable for clinical application in combination with autologous bone grafting [6, 33].

Thus, the intraoperative packing of the mPCL–TCP scaffold with RIA bone grafting adds excellent osteogenic as well as osteoinductive properties without ex vivo cultivation and minimal reported donor-site morbidity [34].


Healing of critical-sized bone defects remains a challenge for the orthopedic surgeon. Despite a better understanding of the difference between fracture healing and non-unions/large-volume bone defect regeneration in recent years, the biological and mechanical requirements for healing remain unchanged. We described a pragmatic and easy approach separating the fundamental pillars of non-unions in three different workflows combined within the surgery making this approach likely a candidate for future routine clinical application.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.


  1. Mekhail AO, Abraham E, Gruber B, Gonzalez M. Bone transport in the management of posttraumatic bone defects in the lower extremity. J Trauma Acute Care Surg. 2004;56(2):368–78.

    Article  Google Scholar 

  2. Mercado-Pagán ÁE, Stahl AM, Shanjani Y, Yang Y. Vascularization in bone tissue engineering constructs. Ann Biomed Eng. 2015;43(3):718–29.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karger C, Kishi T, Schneider L, Fitoussi F, Masquelet AC. Treatment of posttraumatic bone defects by the induced membrane technique. Orthop Traumatol Surg Res. 2012;98(1):97–102.

    Article  CAS  PubMed  Google Scholar 

  4. Masquelet AC. The evolution of the induced membrane technique: current status and future directions. Tech Orthopaed. 2016;31(1):3–8.

    Article  Google Scholar 

  5. Christou C, Oliver RA, Yu Y, Walsh WR. The Masquelet technique for membrane induction and the healing of ovine critical sized segmental defects. PLoS ONE. 2014;9(12):e114122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhou Y, Hutmacher DW, Varawan S-L, Lim TM. In vitro bone engineering based on polycaprolactone and polycaprolactone–tricalcium phosphate composites. Polym Int. 2007;56(3):333–42.

    Article  CAS  Google Scholar 

  7. Woodruff MA, Hutmacher DW. The return of a forgotten polymer—Polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–56.

    Article  CAS  Google Scholar 

  8. Lichte P, Pape HC, Pufe T, Kobbe P, Fischer H. Scaffolds for bone healing: concepts, materials and evidence. Injury. 2011;42(6):569–73.

    Article  CAS  PubMed  Google Scholar 

  9. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007;38(Suppl 4):S3-6.

    Article  Google Scholar 

  10. Pape HC, Evans A, Kobbe P. Autologous bone graft: properties and techniques. J Orthop Trauma. 2010;24(Suppl 1):S36-40.

    Article  PubMed  Google Scholar 

  11. Kim DH, Rhim R, Li L, Martha J, Swaim BH, Banco RJ, et al. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009;9(11):886–92.

    Article  PubMed  Google Scholar 

  12. Sasso RC, Williams JI, Dimasi N, Meyer PR Jr. Postoperative drains at the donor sites of iliac-crest bone grafts. A prospective, randomized study of morbidity at the donor site in patients who had a traumatic injury of the spine. J Bone Joint Surg Am. 1998;80(5):631–5.

    Article  CAS  PubMed  Google Scholar 

  13. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300–9.

    Article  Google Scholar 

  14. Morwood MP, Streufert BD, Bauer A, Olinger C, Tobey D, Beebe M, et al. Intramedullary nails yield superior results compared with plate fixation when using the masquelet technique in the femur and tibia. J Orthop Trauma. 2019;33(11):547–52.

    Article  PubMed  Google Scholar 

  15. Kobbe P, Tarkin IS, Pape HC. Use of the “reamer irrigator aspirator” system for non-infected tibial non-union after failed iliac crest grafting. Injury. 2008;39(7):796–800.

    Article  PubMed  Google Scholar 

  16. Kobbe P, Tarkin IS, Frink M, Pape HC. Voluminous bone graft harvesting of the femoral marrow cavity for autologous transplantation. An indication for the “Reamer-Irrigator-Aspirator-” (RIA-)technique. Der Unfallchirurg. 2008;111(6):469–72.

    Article  CAS  PubMed  Google Scholar 

  17. Reichert JC, Cipitria A, Epari DR, Saifzadeh S, Krishnakanth P, Berner A, et al. A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med. 2012;4(141):141ra93.

    Article  CAS  PubMed  Google Scholar 

  18. Pobloth A-M, Checa S, Razi H, Petersen A, Weaver JC, Schmidt-Bleek K, et al. Mechanobiologically optimized 3D titanium-mesh scaffolds enhance bone regeneration in critical segmental defects in sheep. Sci Transl Med. 2018;10(423):eaam8828.

    Article  CAS  PubMed  Google Scholar 

  19. Crovace AM, Lacitignola L, Forleo DM, Staffieri F, Francioso E, Di Meo A, et al. 3D biomimetic porous titanium (Ti6Al4V ELI) scaffolds for large bone critical defect reconstruction: an experimental study in sheep. Animals. 2020;10(8):1389.

    Article  Google Scholar 

  20. Chen H, Han Q, Wang C, Liu Y, Chen B, Wang J. Porous Scaffold Design for Additive Manufacturing in Orthopedics: A Review. Frontiers in Bioengineering and Biotechnology. 2020;8(609).

  21. Adamzyk C, Emonds T, Falkenstein J, Tolba R, Jahnen-Dechent W, Lethaus B, et al. Different culture media affect proliferation, surface epitope expression, and differentiation of ovine MSC. Stem Cells Int. 2013;2013:387324.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Coelho MJ, Cabral AT, Fernande MH. Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in alpha-MEM and in DMEM. Biomaterials. 2000;21(11):1087–94.

    Article  CAS  PubMed  Google Scholar 

  23. Hollister SJ, Murphy WL. Scaffold translation: barriers between concept and clinic. Tissue Eng B. 2011;17(6):459–74.

    Article  Google Scholar 

  24. Madison RD, Nowotarski PJ. The reamer-irrigator-aspirator in nonunion surgery. Orthoped Clin North Am. 2019;50(3):297–304.

    Article  Google Scholar 

  25. Henrich D, Nau C, Kraft SB, Zollfrank M, Kontradowitz K, Oppermann E, et al. Effect of the harvest procedure and tissue site on the osteogenic function of and gene expression in human mesenchymal stem cells. Int J Mol Med. 2016;37(4):976–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Schmidmaier G, Herrmann S, Green J, Weber T, Scharfenberger A, Haas NP, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone. 2006;39(5):1156–63.

    Article  CAS  PubMed  Google Scholar 

  27. Henkel J, Woodruff MA, Epari DR, Steck R, Glatt V, Dickinson IC, et al. Bone Regeneration based on tissue engineering conceptions—a 21st century perspective. Bone Res. 2013;1(1):216–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sparks DS, Saifzadeh S, Savi FM, Dlaska CE, Berner A, Henkel J, et al. A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction. Nat Protoc. 2020;15(3):877–924.

    Article  CAS  PubMed  Google Scholar 

  29. Xue W, Bandyopadhyay A, Bose S. Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. J Biomed Mater Res B. 2009;91B(2):831–8.

    Article  CAS  Google Scholar 

  30. Lam CX, Hutmacher DW, Schantz JT, Woodruff MA, Teoh SH. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A. 2009;90(3):906–19.

    Article  CAS  PubMed  Google Scholar 

  31. Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27(9):1735–40.

    Article  CAS  PubMed  Google Scholar 

  32. Giannoni P, Mastrogiacomo M, Alini M, Pearce SG, Corsi A, Santolini F, et al. Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regenerat Med. 2008;2(5):253–62.

    Article  CAS  Google Scholar 

  33. Rohner D, Hutmacher DW, Cheng TK, Oberholzer M, Hammer B. In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig. J Biomed Mater Res B Appl Biomater. 2003;66B(2):574–80.

    Article  CAS  Google Scholar 

  34. Le Baron M, Vivona JP, Maman P, Volpi R, Flecher X. Can the Reamer/Irrigator/Aspirator System replace anterior iliac crest grafting when treating long bone nonunion? Orthop Traumatol Surg Res. 2019;105(3):529–33.

    Article  PubMed  Google Scholar 

Download references


The authors gratefully acknowledge the financial support of the Alexander von Humboldt Foundation in the form of a Feodor Lynen Research Fellowship awarded to Markus Laubach.


Open Access funding enabled and organized by Projekt DEAL.

Author information

Authors and Affiliations



All authors made substantial contributions to the conception and design, acquisition of data, analysis and interpretation of data. PK wrote the first draft of the manuscript; FH, HA and DWH contributed significantly to the manuscript preparation; RMS took part in constructive discussions; ML contributed to the conception of the study, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Philipp Kobbe.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editors-in-Chief of this journal.

Competing interests

DWH is a cofounder and shareholder of Osteopore International Pty Ltd, a company specializing in 3D bioresorbable implants to assist with bone healing. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobbe, P., Laubach, M., Hutmacher, D.W. et al. Convergence of scaffold-guided bone regeneration and RIA bone grafting for the treatment of a critical-sized bone defect of the femoral shaft. Eur J Med Res 25, 70 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: